Skip to main content
SpringerLink
Log in

Clinical Practice Guideline for Benign Prostate Hyperplasia in Japan

  • Chapter
Clinical Guidelines in Urological Management

Part of the book series: Recent Advances in Endourology ((ENDOUROLOGY,volume 4))

  • 95 Accesses

Summary

The Japanese Clinical Practice Guideline for Benign prostate Hyperplasia was established in March 1999. The 1999 Guideline was developed according to the methodology of evidence-based medicine by a panel consisting of 10 academic and 10 practicing urologists and 2 epidemiologists, in cooperation with the Japanese Urological Association. The 1999 Guideline consisted of diagnostic and treatment sections. Diagnosis is made according to the International Prostate Symptom Score (I-PSS), the quality-of-life (QOL) score, the maximal flow rate on uroflowmetry, the volume of residual urine, and the estimated prostate volume by ultrasonography. According to the severity of disease, patients are classified into three categories: mild, moderate, and severe. The treatment modalities are watchful waiting, medication, minimal invasive therapy, and surgery. “Mild” patients are recommended to select either watchful waiting or medication; “moderate” patients choose medication, minimal invasive therapy, or surgery; and “severe” patients are recommended to undergo minimal invasive therapy on surgery. The background for the development of the 1999 Guideline is also described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. U.S. Department of Health and Human Services, Agency for Health Care Policy and Research (1994) Clinical Practice Guideline; Benign Prostatic Hyperplasia; Diagnosis

    Google Scholar 

  2. Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy (eds) (1995) Proceedings of the 3rd International Consultation on Benign Prostatic Hyperplasia (BPH) (level V)

    Google Scholar 

  3. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479 (level V)

    PubMed  CAS  Google Scholar 

  4. Koyanagi T, Artibani W, Correa R, Desgranchamps F, DeReijke TM, Govier F, Hanash K, Hirano Y, Hoisaeter PA, Kobayashi S, Kurth KH, Marshall VR, Palmtag H, Wasserman N, Zerbib M (1999) Initial diagnostic evaluation of men with lower urinary tract symptoms. In: Proceedings of the 4th International Consultation on Benign Prostatic hyperplasia (BPH) (level V)

    Google Scholar 

  5. Oesterling JE, Jacobson SJ, Cooner WH (1995) The use of age-specific reference ranges for serum prostatic antigen in men 60 years old or older. J Urol 153:1160–1163 (level V)

    Article  PubMed  CAS  Google Scholar 

  6. Panel for Clinical Trial Guideline on Voiding Dysfunction (1997) Clinical trial guide- line on voiding dysfunction. Igaku Tosho Shuppan Tokyo (level V)

    Google Scholar 

  7. Kaplan SA, Olsson CA, Te AE (1996) The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms; at 2 years of followup. Does it work? J Urol 144:1974–1974 (level III)

    Google Scholar 

  8. Halt T (1989) Urodynamics in benign prostatic hyperplasia; a survey. Prostate (suppl) 2:69–77 (level IV)

    Google Scholar 

  9. Poulson A, Schou J, Puggaard L, Torp-Pedersen S, Nordling J (1994) Prostatic enlargement, symptomatology and pressure/flow evaluation; interrelation in patients with symptomatic BPH. Scand J Urol Nephrol Suppl 157:67–73 (level V)

    Google Scholar 

  10. Mah P, Lim C, Abrams Z, Abrams P (1995) Are urine flow studies adequate for the investigation of older men with lower urinary tract symptoms? Proceedings of the 25th Annual ICS Meeting, Sydney (level V)

    Google Scholar 

  11. De la Rosette JJMCM, Witjes WPJ, Debruyne FMY, Kersten PL, Wrjkstre H (1996) Improved reliability of uroflowmetry investigation; results of a portable home-based uroflowmetry study. Br J Urol 78:385–390 (level IV)

    Article  Google Scholar 

  12. Roehborn CG, Chinn HK, Fulgham PF, Simpkins KL, Peters PC (1986) The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. J Urol 135:1190–1193 (level V)

    Google Scholar 

  13. Barry MJ, Cockett AT, Holtgrewe HL, Mcxconnell JD, Sihelnik SA, Winfield HN (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150: 351–358 (level IV)

    PubMed  CAS  Google Scholar 

  14. Bosch JLHR, Kranse R, van Mastrungt R, Schroder FH (1995) Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism. J Urol 153:689–693 (level III)

    Article  PubMed  CAS  Google Scholar 

  15. Kaplan SA, Te AE, Pressler LB, Olsson CA (1993) Transition zone index (TZI) as a method of assessing benign prostatic hyperplasia; correlation with symptoms, uroflow and detrusor pressure. J Urol 154:1764–1769 (level V)

    Article  Google Scholar 

  16. Hough DM, List A (1991) Reliability of transabdominal ultrasound in the measurement of prostate size. Aust Radiol 35:358–360 (level V)

    Article  CAS  Google Scholar 

  17. Bangma CH, Niemer AQHJ, Grobbee DE, Schroder FH (1996) Transrectal ultrasonic volumetry of the prostate; in vivo comparison of different methods. Prostate 28: 107–110 (level V)

    Article  PubMed  CAS  Google Scholar 

  18. Gerber CS (1996) The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 48:668–675 (level V)

    Article  PubMed  CAS  Google Scholar 

  19. McConnel JD (1994) Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia. Urology 44:156–158 (level V)

    Article  Google Scholar 

  20. El Din KE, De Wildt MJAM, Rosier PFWM, Debruyne FMJ, De la Rosette JJMCH (1996) The correlation between urodynamics and cystoscopic findings in elderly men with voiding complaints. J Urol 155:1018–1022 (level V)

    Article  PubMed  Google Scholar 

  21. Kock WFRM, El Din KE, De Wildt MJAM, Debruyne FMJ, De La Rosette JJMCH (1996) The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 155:186–189 (level V)

    Article  Google Scholar 

  22. Wasserman NF, Lapointe S, Eckmann DR, Rosel PR (1987) Assessment of prostatism; role of intravenous urography. Radiology 165:831–835 (level V)

    PubMed  CAS  Google Scholar 

  23. Aguirre CR, Tallada MB, Mayayo TD, Perales LC, Romero JM (1980) Comparative evaluation of prostate size by transabdominal echography, urethral profile and radiology. J Urol (Paris) 86(9):675–679 (level III)

    CAS  Google Scholar 

  24. Koyanagi T (1974) Diagnostic value of voiding cystourethrography. Jpn J Urol 65: 29–43 (level V)

    CAS  Google Scholar 

  25. Ameda K, Koyanagi T, Nantani M, Taniguchi K, Matsuno T (1994) The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia; correlating the findings with clinical features and outcome after prostatectomy. J Urol 152:443–447 (level V)

    PubMed  CAS  Google Scholar 

  26. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG (1995) A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 332:75–79 (level I)

    Article  PubMed  CAS  Google Scholar 

  27. Buzelin JM, Roth S, Geffriaud-Ricouard C, Delauche-Cavallier MC, and the ALGEBI Study Group (1996) Efficacy and safety of sustained-release alfuzosin 5mg in patients with benign prostatic hyperplasia. Urology 47:335–342 (level I)

    Article  Google Scholar 

  28. Roehborn CG, Oesterling JE, Auerbach S, Kaplan SA, Lloyd LK, Milam DR, et al. for the HYCAT Investigator Group (1996) The Hytrin Community Assessment Trial Study; one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. Urology 47:139–168 (level I)

    Google Scholar 

  29. Roherborn CG, Siegel RL (1996) Safety and efficacy of doxazosin in benign prostatic hyperplasia; a pooled analysis of three double-blind, placebo-controlled studies. Urology 48:406–415 (level I)

    Article  Google Scholar 

  30. Chappie CR, Wyndaele JJ, Nordling J, Boeminghaus F, Ypma AFGVM, Abrams P (1996) Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist; a meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). Eur Urol 29:155–167 (level I)

    Google Scholar 

  31. En LM, Tveter KJ (1993) A prospective, placebo-controlled study of luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia. J Urol 150:359–364 (level I)

    Google Scholar 

  32. Shida K (1986) Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method. Acta Urol Jpn 32:625–648 (level I)

    CAS  Google Scholar 

  33. Stoner E, the Finasteride Study Group (1994) Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. Urology 43: 284–294 (level I)

    Article  PubMed  CAS  Google Scholar 

  34. Stoner E, the Finasteride Study Group (1994) Clinical experience of the detection of prostate cancer in patients with benign prostatic hyperplasia treated with finasteride. J Urol 151:1296–1300 (level I)

    PubMed  CAS  Google Scholar 

  35. Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ, for the Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group (1996) The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 335:533–539 (level I)

    Article  PubMed  CAS  Google Scholar 

  36. Dreikorn K, Borkowski A, Braeckman J, Denis L, Ferrari P, Gerber G, Levin R, Lowe F, Perrin P, Senge T (1997) Other medical therapies. In: Proceedings of the 4th Inter- national Consultation on Benign Prostatic Hyperplasia, pp 663–659 (level V)

    Google Scholar 

  37. Cowles RS III, Kabalin JN, Childs S, Lepor H, Dixon C, Stein BS, Zabbo A (1995) A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 46:155 (level II)

    Article  PubMed  Google Scholar 

  38. Whilfield HN (1996) A randomized prospective multicenter study evaluating the efficacy of interstitial laser coagulation. J Urol 155:318A (level II)

    Google Scholar 

  39. Muschter R (1996) Interstitial laser therapy. Curr Opinion Urol 6:33–38 (level III)

    Article  Google Scholar 

  40. Chappie CR, Rosario DJ, Wasserfaallen M, Woo HH, Nordling J, MiLroy EJG (1995) A randomized study of the Urolume stent vs prostatic surgery. J Urol 153 (suppl): 436A (level II)

    Google Scholar 

  41. Dahlstrand C, Waiden M, Geirsson G, Pettersson S (1993) Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction; a prospective randomized study with a 2-year follow-up. Br J Urol 76:614 (level II)

    Article  Google Scholar 

  42. De la Rosette J, Tubaro A, Trucehi A, Carter SSTC, Hofner K (1995) Changes in pres-sure flow parameters in patients treated by transurethral microwave thermotherapy using Prostasoft 2.0. J Urol 154:1382 (level I)

    Article  PubMed  Google Scholar 

  43. Oesterling JE, Arbor A, Muta MI, Roehrborn CG, Perez-Marrero R, Bruskewitz R, Madison WI, Naslund MJ, Shumaker BP, Perinchary N (1997) A single blind, prospective randomized clinical trial comparing transurethral needle ablation (TUNA) to transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH). J Urol 157:A1282 (level II)

    Google Scholar 

  44. Nakamura K (1996) Treatment of BPH (benign prostatic hypertrophy); high intensity focused ultrasound (HIFU). Curr Ther 14(11): 1–6 (level IV)

    Google Scholar 

  45. Holtgrewe HL, Mebust WK, Dowd JB, Cockett ATK, Peters PC, Proctor C (1989) Transurethral prostatectomy; practice aspects of the dominant operation in American urology. J Urol 141:248–253 (level V)

    PubMed  CAS  Google Scholar 

  46. Rechmann M, Knes JA, Neisey D, Madsen PO, Bruskewitz RC (1995) Transurethral resection versus incision of the prostate; a randomized, prospective study. Urology 145:768–775 (level II)

    Google Scholar 

  47. Cook DJ, et al. (1992) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 102:3050–3056

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Nara Prefectural Medical University, 840 Shijo-cho, Kashihara, Nara, 634-0813, Japan

    Yoshihiko Hirao

  2. Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa-ku, Nagoya, 466-8550, Japan

    Yoshinari Ono & Momokazu Gotoh

Authors
  1. Yoshihiko Hirao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshinari Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Momokazu Gotoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Nagoya University Hospital, Japan

    Shinichi Ohshima M.D., Ph.D. (Vice-President, Professor and Chairman) (Vice-President, Professor and Chairman)

  2. Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, 466-8550, Showa-ku, Nagoya, Japan

    Shinichi Ohshima M.D., Ph.D. (Vice-President, Professor and Chairman) (Vice-President, Professor and Chairman)

  3. Department of Urology, Nara Prefectural Medical University, 840 Shijo-cho, 634-0813, Kashihara, Nara, Japan

    Yoshihiko Hirao M.D. (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 The Japanese Society of Endourology and ESWL

About this chapter

Cite this chapter

Hirao, Y., Ono, Y., Gotoh, M. (2003). Clinical Practice Guideline for Benign Prostate Hyperplasia in Japan. In: Ohshima, S., Hirao, Y. (eds) Clinical Guidelines in Urological Management. Recent Advances in Endourology, vol 4. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65944-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-65944-0_6

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-65946-4

  • Online ISBN: 978-4-431-65944-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation